• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Pharmaceutical Medicine, Biotechnology and European Law

Pharmaceutical Medicine, Biotechnology and European Law

9780521792493
566.94 zł
510.24 zł Save 56.70 zł Tax included
Lowest price within 30 days before promotion: 510.24 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
European law has been faced with increasingly complex issues emerging from rapid developments in pharmaceutical medicine and biotechnology. A team of distinguished European legal practitioners and academics reassess the impact of European law on health care and pharmaceutical law. The essays are grouped under four themes:: Free movement of goods and persons, competition and intellectual property; European drug regulation; Biotechnology; and Product liability and transnational health care litigation. The book reviews the impact of European law on movement of health care professionals and pharmaceuticals, patent and trademark rights, the Product Liability Directive, laws on product liability and intellectual property claims. It examines recent developments in drug regulation, particularly data protection, abridged applications for marketing authorisations and the European Medicines Evaluation Agency. A compelling analysis is made of the Biotechnology Directive morality clauses. This important study offers a valuable resource for the pharmaceutical and biotechnology industries, legal academics and practitioners alike.
Product Details
99036
9780521792493
9780521792493

Data sheet

Publication date
2001
Issue number
1
Cover
hard cover
Pages count
280
Dimensions (mm)
159.00 x 236.00
Weight (g)
578
  • Notes on the contributors; Preface; Introduction Richard Goldberg and Julian Lonbay; Part I. Free Movement of Goods and Persons, Competition and Intellectual Property:: 1. The free movement of goods I:: pharmaceuticals, patents and parallel trade Professor W. R. Cornish; 2. The free movement of goods II:: pharmaceuticals, trade marks and parallel imports Belinda Isaac; 3. The free movement of health care professionals in the European Community Julian Lonbay; 4. EC competition law, drugs and intellectual property:: recent developments Professor Leigh Hancher; Part II. European Drug Regulation:: 5. Data protection and abridged applications for marketing authorisations in the pharmaceutical industry Ian Dodds-Smith; 6. The role of the European Medicines Evaluation Agency (EMEA) in the harmonisation of pharmaceutical regulation Antoine Cuvillier; Part III. Biotechnology:: 7. The morality clauses of the Directive on the Legal Protection of Biotechnological Inventions:: conflict, compromise, and the patent community Deryck Beyleveld, Professor Roger Brownsword and Margaret Llewelyn; Part IV. Product Liability and Transnational Health Care Litigation:: 8. The development risk defence and the European Court of Justice; increased injury costs and the Supplementary Protection Certificate Richard Goldberg; 9. Transnational health care litigation and the Private International Law (Miscellaneous Provisions) Act 1995, Part III Jonathan Harris; Index.
Comments (0)